Patent ID: 11857610
Assignee: CSL BEHRING AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 6:
7. The method of claim 1, wherein the subject suffers from leukemia, lymphoma, myeloma, a genetic hematopoietic disorder, acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), chronic lymphoblastic leukemia (CLL), a myeloproliferative disorder, a myelodysplastic syndrome, multiple myeloma, non-Hodgkin lymphoma, Hodgkin disease, aplastic anemia, pure red cell aplasia, paroxysmal nocturnal hemoglobinuria, Fanconi anemia, thalassemia major, sickle cell anemia, severe combined immunodeficiency (SCID), Wiskott-Aldrich syndrome, hemophagocytic lymphohistiocytosis (HLH), or inborn errors of metabolism.